{"prompt": "['Clinical Study Protocol', 'R2810-ONC-1676 Amendment 7', 'Chronic inflammatory demyelinating polyradiculoneuropathy', 'Demyelinating polyneuropathy', 'Demyelination', 'Autoimmune disorder', 'Autoimmune eye disorder', 'Blood alkaline phosphatase increased', 'Blood creatine phosphokinase increased', 'Blood thyroid stimulating hormone decreased', 'Blood thyroid stimulating hormone increased', 'Cardiac amyloidosis', 'Central nervous system inflammation', 'Chronic gastritis', 'Cutaneous vasculitis', 'Duodenitis', 'Encephalitis', 'Encephalomyelitis', 'Encephalitis allergic', 'Encephalitis autoimmune', 'Immune-mediated encephalitis', 'Noninfective encephalitis', 'Noninfective encephalomyelitis', 'Autoimmune encephalopathy', 'Encephalopathy', 'Immune-mediated endocrinopathy', 'Regeneron Pharmaceuticals, Inc.', 'Page 133 of 145', 'CONFIDENTIAL', 'VV-RIM-00146791-1.( Approved - 14 Apr 2021 GMT-5:00']['Clinical Study Protocol', 'R2810-ONC-1676 Amendment 7', 'Autoimmune endocrine disorder', 'Episcleritis', 'Gastrointestinal perforation', 'Guillain-Barre syndrome', 'Hepatic amyloidosis', \"Basedow's disease\", 'Hyperthyroidism', 'Immune-mediated hyperthyroidism', 'Marine Lenhart syndrome', 'Primary hyperthyroidism', 'Secondary hyperthyroidism', 'Thyrotoxic crisis', 'Thyrotoxic periodic paralysis', 'Toxic goitre', 'Toxic nodular goitre', 'Hypoglossal nerve paralysis', 'Hypophysitis', 'Lymphocytic hypophysitis', 'Hypopituitarism', 'Autoimmune hypothyroidism', 'Hypothyroidic goitre', 'Hypothyroidism', 'Immune-mediated hypothyroidism', 'Myxoedema', 'Regeneron Pharmaceuticals, Inc.', 'Page 134 of 145', 'CONFIDENTIAL', 'VV-RIM-00146791-1. Approved - 14 Apr 2021 GMT-5:00']['Clinical Study Protocol', 'R2810-ONC-1676 Amendment 7', 'Primary hypothyroidism', 'Secondary hypothyroidism', 'Tertiary hypothyroidism', 'Immune-mediated adverse reaction', 'Autoimmune anaemia', 'Autoimmune aplastic anaemia', 'Autoimmune haemolytic anaemia', 'Acute haemorrhagic ulcerative colitis', 'Allergic colitis', 'Autoimmune colitis', 'Autoimmune enteropathy', 'Colitis', 'Colitis erosive', 'Colitis ischaemic', 'Colitis microscopic', 'Colitis ulcerative', \"Crohn's disease\", 'Diarrhoea', 'Diarrhoea haemorrhagic', 'Enterocolitis', 'Enterocolitis haemorrhagic', 'Eosinophilic colitis', 'Immune-mediated enterocolitis', 'Inflammatory bowel disease', 'Regeneron Pharmaceuticals, Inc.', 'Page 135 of 145', 'CONFIDENTIAL', 'VV-RIM-00146791-1.( Approved - 14 Apr 2021 GMT-5:00']\n\n###\n\n", "completion": "END"}